The Brief:

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday.

Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 billion in equity value.

The deal is expected to close in the second quarter of 2026, pending shareholder approval.

MADISON, Wis. — Global healthcare leader Abbott announced Thursday that it has reached a $23 billion deal to acquire Exact Sciences .

According to a press release, the acquisition aims to enhance Abbott's presence in the cancer diagnostics segment.

Shareholders of Exact Sciences will receive $105 per common share, representing a total equity value of approximately $21 billion under this agreement, with an estimated enterprise value of $23 billion. The acquisition is

See Full Page